Argomenti e Notizie
sull'Osteoporosi
con raccolte
bibliografiche su
PubMed Logo
a cura del
Dott. C.Tarozzi
Bologna
Anno 26°
Num. 148
Recens. 3000
Aderiamo allo standard HONcode per l'affidabilitŕ dell'informazione medica questo sito aderisce fin dal 2004 allo standard HONcode per l'affidabilità dell'informazione medica. Verifica qui.
Rassegna - Alimenti e Calcio - Questionari - T-Score - Valore di un Test - Calcolatori - Contatti - Digitalia - Radioactivity
Ricerca nell'archivio di questo sito...
 ?  
Nuova bibliografia selezionata fino al mese di dicembre 2020 (recensioni 22) Ordina per Autore - Titolo - Rivista
Thompson JC, Wanderman N, Anderson PA, Freedman BA.
Abaloparatide and the Spine: A Narrative Review.
Clin Interv Aging. 2020 Jun 29;15:1023-1033.

Tile L, Cheung AM.
Atypical femur fractures: current understanding and approach to management.
Ther Adv Musculoskelet Dis. 2020 Aug 21;12:1759720X20916983.

Casiano VE, Dydyk AM, Varacallo M.
Back Pain.
2020 Oct 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan–.

Kendler D, Chines A, Clark P, Ebeling PR, McClung M, Rhee Y, Huang S, Stad RK.
Bone Mineral Density After Transitioning From Denosumab to Alendronate.
J Clin Endocrinol Metab. 2020 Mar 1;105(3):e255–64.

Ramchand SK, David NL, Leder BZ, Tsai JN.
Bone Mineral Density Response With Denosumab in Combination With Standard or High-Dose Teriparatide: The DATA-HD RCT.
J Clin Endocrinol Metab. 2020 Mar 1;105(3):890–7.

Razaq A, Khan S, Hassan J, Malik BH, Razaq M.
Comparing the Efficacy and Safety of Denosumab with Bisphosphonates in Increasing Bone Mineral Density in Patients with Prostate Cancer and Breast Cancer on Antihormonal Treatment.
Cureus. 2019 Dec 17;11(12):e6401.

Giustina A, Adler RA, Binkley N, Bollerslev J, Bouillon R, Dawson-Hughes B, Ebeling PR, Feldman D, Formenti AM, Lazaretti-Castro M, Marcocci C, Rizzoli R, Sempos CT, Bilezikian JP.
Consensus statement from 2nd International Conference on Controversies in Vitamin D. Rev Endocr Metab Disord. 2020
Mar;21(1):89-116.

Leder BZ, Mitlak B, Hu MY, Hattersley G, Bockman RS.
Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis.
J Clin Endocrinol Metab. 2020 Mar 1;105(3):938–43.

Valdes A, Bajaj T.
Estrogen Therapy. 2020 May 30.
In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan–.

Merlijn T, Swart KMA, Van Der Horst HE, Netelenbos JC, Elders PJM.
Fracture prevention by screening for high fracture risk: a systematic review and meta-analysis.
Osteoporos Int. 2020 Feb;31(2):251-257.

Rozenberg S, Bruyère O, Bergmann P, Cavalier E, Gielen E, Goemaere S, Kaufman JM, Lapauw B, Laurent MR, De Schepper J, Body JJ.
How to manage osteoporosis before the age of 50.
Maturitas. 2020 Aug;138:14-25.

Rozenberg S, Al-Daghri N, Aubertin-Leheudre M, Brandi ML, Cano A, Collins P,Cooper C, Genazzani AR, Hillard T, Kanis JA, Kaufman JM, Lambrinoudaki I, Laslop A, McCloskey E, Palacios S, Prieto-Alhambra D, Reginster JY, Rizzoli R, Rosano G, Trémollieres F, Harvey NC.
Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?
Osteoporos Int. 2020 Dec;31(12):2271-2286.

Noh JY, Yang Y, Jung H.
Molecular Mechanisms and Emerging Therapeutics for Osteoporosis.
Int J Mol Sci. 2020 Oct 15;21(20):7623.

Iolascon G, Moretti A, Toro G, Gimigliano F, Liguori S, Paoletta M.
Pharmacological Therapy of Osteoporosis: What's New?
Clin Interv Aging. 2020 Mar 26;15:485-491.

Zhang N, Zhang ZK, Yu Y, Zhuo Z, Zhang G, Zhang BT.
Pros and Cons of Denosumab Treatment for Osteoporosis and Implication for RANKL Aptamer Therapy.
Front Cell Dev Biol. 2020 May 14;8:325.

Angata T.
Siglec-15: a potential regulator of osteoporosis, cancer, and infectious diseases.
J Biomed Sci. 2020 Jan 3;27(1):10.

Brancatella A, Marcocci C.
TSH suppressive therapy and bone.
Endocr Connect. 2020 Jul;9(7):R158-R172.

Vall H, Parmar M.
Teriparatide.
2020 Jun 4. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan–.

Delitala AP, Scuteri A, Doria C.
Thyroid Hormone Diseases and Osteoporosis.
J Clin Med. 2020 Apr 6;9(4):1034.

Amrein K, Scherkl M, Hoffmann M, Neuwersch-Sommeregger S, Köstenberger M, Tmava Berisha A, Martucci G, Pilz S, Malle O.
Vitamin D deficiency 2.0: an update on the current status worldwide.
Eur J Clin Nutr. 2020 Nov;74(11):1498-1513.

Xie J, Li S, Xiao L, Ouyang G, Zheng L, Gu Y, Gao C, Han X.
Zoledronic acid ameliorates the effects of secondary osteoporosis in rheumatoid arthritis patients.
J Orthop Surg Res. 2019 Dec 10;14(1):421.

Endo Y, Funayama H, Yamaguchi K, Monma Y, Yu Z, Deng X, Oizumi T, Shikama Y, Tanaka Y, Okada S, Kim S, Kiyama T, Bando K, Shima K, Suzuki H, Takahashi T.
[Basic Studies on the Mechanism, Prevention, and Treatment of Osteonecrosis of the Jaw Induced by Bisphosphonates].
Yakugaku Zasshi. 2020;140(1):63-79. Japanese.

(Vers. 2.1)  Modificato il 6-12-2020
http://www.tarozzi.net   
questo sito aderisce ai principi HONCODE    disclaimer